Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00199628|
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : January 15, 2019
Problems of compatibility between a mother and her child are frequent. The most well-known case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which can induce severe anemia of the fetus.
The investigators recently proved that incompatibility between mother and child can concern an organ leading to a tissular alloimmunization. For example, neonatal membranous glomerulonephritis (a kidney disease) can result from this mechanism.
The purpose of this network is to detect and study neonatal diseases induced by tissular fetomaternal alloimmunization. The detection of these diseases will be performed by the mother's serum analysis.
|Condition or disease|
|Glomerulonephritis, Membranous Neonatal Diseases and Abnormalities Hemochromatosis|
|Study Type :||Observational|
|Actual Enrollment :||100 participants|
|Official Title:||Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization|
|Actual Study Start Date :||September 2005|
|Actual Primary Completion Date :||August 2013|
|Actual Study Completion Date :||August 2014|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00199628
|Limoges University Hospital|
|Limoges, France, 87042|
|Principal Investigator:||Vincent Guigonis, MD||Department of Pediatrics, Limoges University Hospital|